← brief for 2026-10-19 · Slowing decline
Health technology assessment of long-acting erythropoiesis-stimulating agents for the treatment of renal anemia in China
Key takeaways
Who did this work
Wang X (Department of Pharmacy, The Affiliated Huaian No.1 People’s Hospital of Nanjing Medical University , , ,) · Li H (Department of Pharmacy, The Affiliated Huaian No.1 People’s Hospital of Nanjing Medical University , , ,) · Zhang Y (Department of Pharmacy, The Affiliated Huaian No.1 People’s Hospital of Nanjing Medical University , , ,) · Duan Y (Department of Pharmacy, The Affiliated Huaian No.1 People’s Hospital of Nanjing Medical University , , ,)
Source
Article · Europe PMC, CKD · 2026-10-19
https://europepmc.org/article/PMC/PMC13672644